Connect with us
Become a Member

April 15 2PM COCA update: Johnson & Johnson/Janssen COVID-19 Vaccine and Cerebral Venous Sinus Thrombosis with Thrombocytopenia – Update for Clinicians on Early Detection and Treatment

Posted about 4 years ago by Meredith Roberts

Johnson & Johnson/Janssen COVID-19 Vaccine and Cerebral Venous Sinus Thrombosis with Thrombocytopenia – Update for Clinicians on Early Detection and Treatment

Date: Thursday, April 15, 2021

Time: 2:00 pm - 3:00 pm (ET)

This COCA Call will present the latest evidence on cerebral venous sinus thrombosis (CVST) with thrombocytopenia associated with the administration of the Johnson & Johnson/Janssen COVID-19 vaccine. Speakers will discuss what is known about CVST, the importance of early detection, and updated vaccine recommendations.

If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends.

The slide set will be available under "Call Materials" on the COCA Call webpage the day of the call.

A few minutes before the webinar starts, please click on the Zoom link below to join: https://www.zoomgov.com/j/

1614336614?pwd=ZVhQUHoya

G4zVFdua2czcE9EU20wUT09

Or iPhone one-tap : 

US: +16692545252,,1614336614#,,,,*160026# 

Or Telephone: Dial (for higher quality, dial a number based on your current location): 

US +1 669 254 5252 or

+1 646 828 7666 or

+1 551 285 1373 or

+1 669 216 1590

Webinar ID: 161 433 6614

Passcode:160026

COCA Call Objectives

At the conclusion of the session, the participant will be able to accomplish the following—
  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC’s role in the topic covered during the presentation.
  3. Describe the topic’s implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
  5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.

Presenters

Sara Oliver, MD

LCDR, U.S. Public Health Service

Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group

COVID-19 Response

Centers for Disease Control and Prevention

 

Tom Shimabukuro, MD, MPH, MBA

CAPT, U.S. Public Health Service

Vaccine Safety Team Lead

COVID-19 Response

Centers for Disease Control and Prevention